Dayvigo
Payments companies reported to CMS as associated with Dayvigo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dayvigo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dayvigo
These are the largest totals companies reported as associated with Dayvigo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Phyllis Zee | Chicago, IL | Sleep Medicine (Psychiatry & Neurology) | $26,130.86 |
| Ruth Benca | Winston Salem, NC | Psychiatry | $11,632.50 |
| Damon Raskin | Pacific Palisades, CA | Internal Medicine | $8,017.06 |
| Brendan Lucey | Saint Louis, MO | Neurology (Psychiatry & Neurology) | $6,960.00 |
| Richard Bogan | Columbia, SC | Pulmonary Disease | $6,525.00 |
| Seema Khosla | Fargo, ND | Pulmonary Disease | $6,030.00 |
| Andrew Krystal | Durham, NC | Psychiatry | $5,692.50 |
| Leslie Citrome | Pomona, NY | Psychiatry | $2,700.00 |
| Rakesh Jain | Lake Jackson, TX | Psychiatry | $1,575.00 |
| David Neubauer | Baltimore, MD | Psychiatry | $1,200.00 |
Prescribed Dayvigo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.